2012
DOI: 10.1667/rr2504.1
|View full text |Cite
|
Sign up to set email alerts
|

Biological Effects of Inhaled239PuO2in Beagles

Abstract: Seven groups of 8-24 Beagle dogs, exposed to (239)PuO(2) aerosols by inhalation [mean initial lung depositions (ILD) of 0.0, 0.14, 0.63, 3.2, 13, 44 and 210 kBq] were observed throughout their lives to determine tissues at risk and dose-effect relationships. The mean average pulmonary retention half-time of (239)Pu was 1,192 days. Most (70%) of the plutonium recovered at death in dogs surviving >10 years after exposure was found in the thoracic lymph nodes with ∼15% in lung, ∼10% in liver and ∼2% in bone. Eigh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 55 publications
0
8
0
Order By: Relevance
“…The cancer hazard associated with 239 Pu is dependent on the radiation dose, dose rate and dose distribution (Jee 1976; Brooks et al 1983; Park et al 2012; McClellan 2014). This research has demonstrated that 239 Pu is not unique and that the biological response to the alpha particle from 239 Pu is the same as any other alpha emitter.…”
Section: Scientific Research and Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The cancer hazard associated with 239 Pu is dependent on the radiation dose, dose rate and dose distribution (Jee 1976; Brooks et al 1983; Park et al 2012; McClellan 2014). This research has demonstrated that 239 Pu is not unique and that the biological response to the alpha particle from 239 Pu is the same as any other alpha emitter.…”
Section: Scientific Research and Resultsmentioning
confidence: 99%
“…Such data was combined with other information by standard setting groups resulting in a radiation weighting factor of 20 being used when comparing the risks from alpha emitters to that from beta-gamma exposures (NCRP 1990; US NRC 1992). However, extensive studies in beagle dogs demonstrated that the important risk (i.e., for radiation-induced cancer) from 239 Pu is only about a factor of 6 to 10 times as effective as radiation exposure to low LET radiation (Muggenberg et al 2008; Park et al 2012; McClellan 2014). These data have been compared to human data following exposure at the Mayak facility in Russia (Gilbert et al 2007, 2013a and b) that occurred during development of atomic weapons.…”
Section: Scientific Research and Resultsmentioning
confidence: 99%
“…Such data combined with other information resulted in a radiation weighting factor of 20 being used when comparing the risks from alpha emitters to that from beta-gamma exposures (NCRP 1993). However, extensive studies in beagle dogs demonstrate that the cancer risk from 239/240 Pu is only about a factor of 6 to 10 times as effective as acute radiation exposure to low-LET radiation (Park et al 2012; Muggenberg et al 2008; McClellan 2014). These data have been compared to human data following exposure at the Mayak facility in Russia that occurred during development of atomic weapons.…”
Section: Discussionmentioning
confidence: 99%
“…This factor was in part driven by the observation that the frequency of chromosome aberrations induced in the liver were 20 times higher for alpha particles relative to chronic exposure to low-LET radiation. Recent research has suggested that for the induction of cancer from plutonium, the effectiveness factor relative to low LET protracted exposure is between 6 and 10 (NCRP 2001; McClellan 2014; Muggenberg et al 2008; Park et al 2012). This would reduce the risk by about a factor of 2.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, α-irradiation, leading to cancer in the presence of tissue fibrosis, is indicated in humans and animals for the irradiated lung (pulmonary fibrosis) following the inhalation of α-emitters, 31- 34 liver (cirrhosis) following thorium-232 ( 232 Th) colloid administration 35,36 and in the skeleton (peritrabecular fibrosis/osteonecrosis) following intakes of bone-seeking radionuclides—including americium-241 ( 241 Am) 37 and radium-226 ( 226 Ra; first described for 226 Ra in man by Lloyd and Henning 38 ). In dogs injected with 239 Pu, the percentage of animals with both osteosarcoma and peritrabecular fibrosis was the same over a wide range of administered doses and the prevalence of adenocarcinomas and squamous lung tumors closely matched pulmonary fibrosis.…”
Section: Commentarymentioning
confidence: 99%